Zdrowie i gospodarka · 18/12/1997

Regulatory Changes Affect Medical Device Tracking and Postmarket Surveillance in the United States

The U.S. Food and Drug Administration (FDA) has announced updates to its medical device tracking and postmarket surveillance policies, which will impact manufacturers and regulatory bodies